q&a: equal treatment access in rural communities - blood cancer onctalk 2023
Published 4 months ago • 10 plays • Length 3:55Download video MP4
Download video MP3
Similar videos
-
3:49
q&a: how do oncologists determine treatment orders? - blood cancer onctalk 2023
-
3:36
q&a: financial or location limitations to bispecific antibody treatments? -blood cancer onctalk 2023
-
2:39
q&a: bispecific treatment in lymphoma: key doctor discussions - blood cancer onctalk 2023
-
3:14
grace welcome video 2023 blood cancer onctalk
-
2:25
maintenance treatment in multiple myeloma - blood cancer onctalk
-
4:11
treatment options for newly diagnosed aml: venetoclax and midostaurin - blood cancer onctalk
-
1:05
q&a: does bispecific treatment for lymphoma affect fertility? - blood cancer onctalk 2023
-
3:13
q&a: is multiple myeloma a myelogenous cancer? - blood cancer onctalk 2023
-
4:33
q&a: how successful are bone marrow transplants for lymphoma? - blood cancer onctalk 2023
-
1:19
q&a: do bispecifics cure diffuse large b-cell lymphoma? - blood cancer onctalk 2023
-
3:40
should cellular therapies be moved to first line treatment? - blood cancer onctalk
-
1:55
how do i find clinical trials? - blood cancer onctalk
-
2:52
location of disease: can metastatic locations predict success of treatment? - onctalk 2022
-
2:04
newly diagnosed al amyloidosis: current standard of care - blood cancer video library 2023
-
1:36
q&a: average length of radiation treatment for patients with stage iv disease? - onctalk lung 2023
-
6:08
chemo /- immunotherapy for mesothelioma-leading developments & current questions in lung cancer
-
9:36
gracecast-021_lung-cancer_stage iiia management options
-
3:11
continuing immunotherapy beyond progression. in which patients is this appropriate
-
2:40
gracecastuc111_kidney_wht are the options for second line treatment of kidney cancer?